Elke M. Erne
Bolzano, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Mapping HIV infection and sex-based differences among sub-Saharan African migrants in Northeast Italy: a multicenter study.
Journal: Pathogens and global health
Published: September 08, 2026
A multicentre real-life prospective cohort study on effectiveness, durability and safety of long-acting injectable cabotegravir and rilpivirine in northern Italy: the LONGITUDE study.
Journal: The Journal of antimicrobial chemotherapy
Published: May 14, 2025
Dermatological Presentation of Strongyloides stercoralis Infection in Two Elderly Italian Inpatients.
Journal: Pathogens (Basel, Switzerland)
Published: July 03, 2024
Autoantibodies neutralizing type I IFNs underlie severe tick-borne encephalitis in ∼10% of patients.
Autoantibodies neutralizing type I IFNs underlie severe tick-borne encephalitis in ∼10% of patients.
Journal: The Journal of experimental medicine
Published: April 09, 2024
Real-life comparison of mortality in patients with SARS-CoV-2 infection at risk for clinical progression treated with molnupiravir or nirmatrelvir plus ritonavir during the Omicron era in Italy: a nationwide, cohort study.
Journal: The Lancet regional health. Europe
Published: May 09, 2023
Population Pharmacokinetic and Pharmacodynamic Analysis of Dalbavancin for Long-Term Treatment of Subacute and/or Chronic Infectious Diseases: The Major Role of Therapeutic Drug Monitoring.
Journal: Antibiotics (Basel, Switzerland)
Published: May 30, 2022
Psychiatric Disorders after Switching to Dolutegravir: A Case Report of a 59-Year-Old Virosuppressed HIV-1 Positive Woman.
Journal: Case reports in infectious diseases
Published: August 19, 2019
In Chronic Hepatitis C Infection, Myeloid-Derived Suppressor Cell Accumulation and T Cell Dysfunctions Revert Partially and Late After Successful Direct-Acting Antiviral Treatment.
Journal: Frontiers in cellular and infection microbiology
Published: March 01, 2019
Forecasting Hepatitis C liver disease burden on real-life data. Does the hidden iceberg matter to reach the elimination goals?
Journal: Liver international : official journal of the International Association for the Study of the Liver
Published: March 23, 2018
Modeling cost-effectiveness and health gains of a "universal" versus "prioritized" hepatitis C virus treatment policy in a real-life cohort.
Journal: Hepatology (Baltimore, Md.)
Published: February 15, 2017
Genotype-specific mutations in the polymerase gene of hepatitis B virus potentially associated with resistance to oral antiviral therapy.
Journal: Antiviral research
Published: June 05, 2012
Showing 1-11 of 11
Last Updated: 09/26/2026